GSK to study flu vaccine already sold to U.S.

12/9/2004 | Reuters

GlaxoSmithKline said it would begin a late-stage study of its Fluarix flu vaccine, which U.S. officials already have agreed to buy on an emergency basis to help ease the shortage of flu vaccine. GSK plans a 1,000-person trial in four U.S. locations this month and expects to submit an application to the FDA for approval of the vaccine next year. The U.S. announced earlier this week it would buy up to 4 million doses of the vaccine, produced at a plant in Germany.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ